SBT101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SBT101, covering 2025-10-31 to 2026-08-26. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN) [Phase 1, Phase 2]